文献速递瓣膜外科先天性心脏病外科

婴幼儿与儿童二尖瓣置换:使用15毫米机械瓣的经验

Mitral Valve Replacement in Infants and Children: Experience Using a 15-mm Mechanical Valve.
PubMed 文献 · Ann Thorac Surg · 2023-05-05

单中心回顾性分析2009至2022年15例患儿共16次15毫米机械瓣二尖瓣置换,无手术死亡,术后恢复较快,但27%发生晚期死亡,31%的出院患者因国际标准化比值异常在30天内再入院,抗凝管理是显著挑战。

要点

  • 15例患儿共接受16次15毫米机械瓣二尖瓣置换,无手术死亡。
  • 术后中位插管1.5天、心脏重症监护室停留6天、总住院17.0天。
  • 13例出院回家患者中4例(31%)因国际标准化比值异常在30天内再入院。

核心结论

  • 本组为迄今最大的单中心15毫米机械瓣二尖瓣置换队列,主要不良事件率低于既往报道,瓣膜耐久,术后恢复快,但该年龄组适当且一致的抗凝管理是显著挑战。

研究设计与样本

  • 单中心回顾性病历审查,纳入2009年至2022年接受15毫米机械瓣二尖瓣置换的患者,采用描述性统计分折短期和长期结局。

主要发现

  • 15例患者共接受16次15毫米机械瓣二尖瓣置换,无手术死亡。
  • 手术时中位年龄6.2个月(四分位距4.4-13.7),中位体重5.16 kg(四分位距4.5-6.9)。
  • 10枚植入物(66%)置于瓣环上位置。
  • 术后中位插管时间1.5天(四分位距1.0-3.75),心脏重症监护室停留6天(四分位距3-13.5),总住院17.0天(四分位距12-48.5)。
  • 3例患者(20%)术后发生主要不良事件;13例出院回家患者中4例(31%)因国际标准化比值低于或高于治疗范围在30天内再入院;无手术死亡,4例晚期死亡(27%)。

关键数值与推荐

  • 6例患者后续接受再次二尖瓣置换,距第二次二尖瓣置换的中位时间6.8年(四分位距3.6-8.9)。
  • 6例患者仍保留原15毫米机械瓣,置入后中位时间4.7年。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Reports using a 15-mm mechanical valve for mitral valve replacement (MMVR) in children are limited. We review our center's operative and postoperative experience with this valve. METHODS: We performed a single-center retrospective chart review identifying patients having undergone MMVRs between 2009 and 2022. We analyzed short- and long-term outcomes using descriptive statistics. RESULTS: Fifteen patients underwent 16 MMVRs with no operative deaths. The median age and weight at the time of operation was 6.2 months (interquartile range [IQR] 4.4-13.7), and 5.16 kg (IQR 4.5-6.9), respectively. Ten implants (66%) were placed in the supraannular position. Median postoperative duration of intubation was 1.5 days (IQR 1.0-3.75), cardiac intensive care unit length of stay was 6 days (IQR 3-13.5), and overall hospital length of stay was 17.0 days (IQR 12-48.5). Three patients (20%) experienced major adverse events postoperatively. Four of 13 patients discharged home (31%) required readmission within 30 days for subtherapeutic/supratherapeutic international normalized ratio values. There were no surgical mortalities and 4 late mortalities (27%). Six patients underwent subsequent MMVR at a median time to second MMVR of 6.8 (IQR 3.6-8.9) years. There are 6 patients with the original 15-mm MVR at a median time of 4.7 years since placement. CONCLUSIONS: We present the largest single-center cohort of patients having undergone 15-mm MMVR. Our experience is distinguished by a lower rate of major adverse events than previously reported, durability of the device, and a rapid postoperative recovery time. Appropriate and consistent anticoagulation is a notable challenge in this age group.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Mills M, John M, Tang R, et al. Mitral Valve Replacement in Infants and Children: Experience Using a 15-mm Mechanical Valve. Ann Thorac Surg. 2023. PMID: 37150274. doi:10.1016/j.athoracsur.2023.04.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。